age-related macular degeneration

The Next Blockbusters Could Be Balms For Aging Eyes
Investors.com
Thu, 09/3/15 - 09:10 am
age-related macular degeneration
Bayer
Regeneron
Ophthotech
Allergan
Novartis
Applied Genetic Technologies
Avalanche Biotechnologies
Roche
Lucentis
Eylea
Italy's move to fund unapproved use of Roche's Avastin alarms the industry
Fierce Pharma
Wed, 06/11/14 - 10:47 am
Italy
Roche
Avastin
age-related macular degeneration
Using Avastin for Eye Disorder Could Save U.S. $3 Billion
Bloomberg
Mon, 06/2/14 - 06:13 pm
Avastin
Roche
Lucentis
age-related macular degeneration
diabetic macular edema
StemCells advances HuCNS-SC clinical trial to final cohort
The Fly on the Wall
Thu, 05/22/14 - 08:39 am
StemCells
HuCNS-SC
clinical trials
age-related macular degeneration
BioTime Joins Advanced Cell Technology In The AMD Race
Seeking Alpha
Mon, 03/24/14 - 10:41 am
BioTime
Advanced Cell Technology
age-related macular degeneration
Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for Ocular Diseases - Angel Broking
Equity Bulls
Sat, 10/5/13 - 10:26 am
Sun Pharma
Intrexon
wet age-related macular degeneration
age-related macular degeneration
macular
edema
uveitis
diabetic retinopathy
Regeneron Shareholders Watching Optina Trial Closely
Seeking Alpha
Thu, 05/23/13 - 11:32 am
Optina
Regeneron
Novartis
Eylea
Ampio Pharmaceuticals
age-related macular degeneration
Lucentis
Regeneron Pharma raises sales forecast for Eylea
Yahoo/AP
Sat, 05/4/13 - 10:26 am
Regeneron
Eylea
age-related macular degeneration
macular degeneration
Regeneron's Flagship Drug Treats Blindness In Seniors
Investors.com
Fri, 04/12/13 - 09:56 am
Regeneron
age-related macular degeneration
Eylea
Age-Related Macular Degeneration: A Promising Investment Opportunity
Seeking Alpha
Tue, 01/22/13 - 10:43 am
age-related macular degeneration
Lpath
Merck
Pfizer
Bristol-Myers Squibb
Roche
ShangPharma
2 Drug Approvals and Shares Drop? That's Biotech!
Motley Fool
Tue, 09/25/12 - 09:46 am
Regeneron
Eylea
macular edema
age-related macular degeneration
Valeant buys Visudyne drug from QLT; QLT stock jumps
Reuters
Mon, 09/24/12 - 11:20 am
Valeant Pharmaceuticals
Visudyne
QLT
age-related macular degeneration
Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration
Yahoo/PR NewsWire
Sat, 11/19/11 - 11:36 am
Regeneron
Eylea
macular degeneration
age-related macular degeneration
VA Reinstates Avastin Usage For Eye Disease
Pharmalot
Thu, 11/10/11 - 01:13 pm
Veterans Administration
Avastin
Lucentis
age-related macular degeneration
Genentech
Regeneron Soars on Eye-Drug Rival Setback
TheStreet.com
Wed, 09/21/11 - 11:24 pm
Regeneron
Roche
Avastin
wet-AMD
age-related macular degeneration
Regeneron Pharmaceuticals Shares Plunged: What You Need to Know
Motley Fool
Sat, 09/10/11 - 09:55 am
Regeneron
Eylea
age-related macular degeneration
Off-Label Avastin Use, Medicare And Saving Money
Pharmalot
Wed, 09/7/11 - 09:54 am
Medicare
off-label
Avastin
Roche
Genentech
age-related macular degeneration
pSivida on the Cusp of Big Breakthrough
Seeking Alpha
Tue, 07/5/11 - 04:39 pm
Pfizer
pSivida
diabetic macular edema
injectables
age-related macular degeneration
Durasert
glaucoma
Bayer Seeks European Approval
Yahoo/Zacks
Sat, 06/11/11 - 10:27 am
Bayer
VEGF Trap-Eye
age-related macular degeneration
Novartis girds for rival Regeneron eye drug
Reuters
Fri, 05/13/11 - 10:42 am
Regeneron
Novartis
Lucentis
VEGF Trap-Eye
age-related macular degeneration

Pages